Interleukin 4 production by peripheral blood lymphocytes in patients with classical Hodgkin lymphoma

Leukemia Research

Volumn 28, Issue 2, 2004, Pages 159-166

  Mainou Fowler, T ^a   Proctor, S J ^a   Taylor, P R A ^a  

^a Dept of Haematological Sciences   (United Kingdom)

Author keywords

Hodgkin lymphoma; Interleukin 4; T cell subsets

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 4;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL SUBPOPULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPLASM; FEMALE; FLUORESCENCE; HODGKIN DISEASE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE;

EID: 0345275999     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00216-9     Document Type: Article

References (41)

1. Colby T.V., Hoppe R.T., Warnke R.A. Hodgkin's disease and autopsy. Cancer. 47:1981;1852-1862.
2. Poppema S. Immunobiology of Hodgkin's disease. Baillieres Clin. Haematol. 9:1996;447-457.
3. Young R.C., Corder M.P., Haynes H.A., De Vita T. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am. J. Med. 52:1972;63-72.
4. Gaines J.D., Gilmer M.A., Remington J.S. Deficiency of lymphocyte antigen recognition in Hodgkin's disease. Natl. Cancer Inst. Monogr. 36:1973;117-121.
5. Engelman E.G., Benike C.J., Hoppe R.T., Kaplan H.S., Berberich F.R. Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect. J. Clin. Invest. 66:1980;149-158.
6. Romagnani S., Del Prete G.F., Maggi E., Bosi A., Bernardi F., Ponticelli P., et al. Displacement of T lymphocytes with the 'helper/inducer' phenotype from peripheral blood to lymphoid organs in untreated patients with Hodgkin's disease. Scand. J. Haematol. 31:1983;305-314.
7. Ayoub J.P., Palmer J.L., Huh Y., Cabanillas F., Younes A. Therapeutic and prognostic implications of peripheral blood lymphopenia in patients with Hodgkin's disease. Leuk. Lymphoma. 34:1999;519-527.
8. Blay J.Y., Farcet J.P., Lavaud A., Radoux D., Chouaib S. Serum concentrations of cytokines in patients with Hodgkin's disease. Eur. J. Cancer. 30A:1994;321-324.
9. Nadali G., Vinante F., Ambrosetti A., Todeschini G., Veneti D., Zanotti R., et al. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis. J. Clin. Oncol. 12:1994;793-797.
10. Gorschluter M., Bohlen H., Hasenclever D., Diehl V., Tesch H. Serum cytokine levels correlate with clinical parameters in Hodgkin's disease. Ann. Oncol. 6:1995;477-482.
11. Kurzrock R. Cytokine deregulation in hematological malignancies: clinical and biological implications. Clin. Cancer Res. 3:1997;2581-2584.
12. Hsu S.M., Waldron J.W., Hsu P.L., Hough A.J. Cytokines in malignant lymphomas: review and prospective evaluation. Hum. Pathol. 24:1993;1040-1057.
13. Gruss H.J., Pinto A., Duyster J., Poppema S., Herrmann F. Hodgkin's disease: a tumor with disturbed immunological pathways. IT. 18:1997;156-163.
14. Serrano D., Ghiotto F., Roncella S., Airoldi I., Cutrona G., Truini M. The patterns of IL2, IFN-γ, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar. Haematologica. 82:1997;542-549.
15. Ford R.J., Tsao J., Kouttab N.M., Sahastabuddhe C.G., Mehta S.R. Association of an interleukin abnormality with the T cell defect in Hodgkin's disease. Blood. 64:1984;386-392.
16. Soulillou J.P., Douillard J.Y., Vie H., Harousseau J.L., Guenell L., le Mevel-le Pourhiet A., et al. Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease. Eur. J. Cancer Clin. Oncol. 21:1985;935-939.
17. Zamkoff K.W., Reeves W.G., Paolozzi F.P., Poiesz B.J., Comis R.L., Tomar R.H. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease. Clin. Immunol. Immunopathol. 35:1985;111-124.
18. Damle R.N., Advani S.H., Gangal S.G. Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease. Cancer Immunol. Immunother. 34:1991;205-219.
19. Romagnani S. Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? IT. 13:1992;3781-3793.
20. Powrie F., Coffman R.L. Cytokine regulation of T-cell function: potential and therapeutic intervention. IT. 14:1993;270-274.
21. Clerici M., Ferrario E., Trabattoni D., Viviani S., Bonfanti V., Venzon D.J. Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease. Eur. J. Cancer. 30A:1994;1464-1470.
22. Yssel H., Schneider P., Spits H. Production of IL4 by human T cells and regulation of differentiation of T-cell subsets by IL4. Res. Immunol. 144:1993;610-616.
23. Callard R.E. Immunoregulation by interleukin-4 in man. Br. J. Haematol. 78:1991;293-299.
24. Rush J.S., Hodgkin P.D. B cells activated via the CD40 and IL4 undergo a division burst but require continued stimulation to maintain division. Eur. J. Immunol. 31:2001;1150-1159.
25. Tony H.P., Lehrnbecher T., Merz H., Sebald W., Wilhelm M. Regulation of IL-4 responsiveness in lymphoma B cells. Leuk. Res. 15:1991;911-919.
26. Mainou-Fowler T., Prentice A.G. Modulation of apoptosis in B-cell chronic lymphocytic leukaemia. Leuk. Lymphoma. 2:1996;369-377.
27. Mainou-Fowler T., Proctor S.J., Miller S., Dickinson A.M. Expression and production of interleukin 4 in B-cell chronic lymphocytic leukaemia. Leuk. Lymphoma. 42:2001;689-698.
28. + T-cell subset in B-cell chronic lymphocytic leukaemia. Br. J. Haematol. 104:1999;589-599.
29. Raziuddin S., Sheikha A., Abu-Eshy S., Al-Janadi M. Regulation of interleukin-4 production and cytokine-induced growth potential in peripheral T-cell non-Hodgkin's lymphomas. Br. J. Haematol. 100:1998;310-316.
30. Merz H., Fliedner A., Orscheschek K., Binder T., Sebald W., Muller-Hermelink H.K., et al. Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. Am. J. Pathol. 139:1991;1173-1180.
31. Skinnider B.F., Mak T.W. The role of cytokines in classical Hodgkin lymphoma. Blood. 99:2002;4283-4297.
32. Mainou-Fowler T., Copplestone J.A., Prentice A.G. Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells. J. Clin. Pathol. 48:1995;482-487.
33. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. IT. 17:1996;138-146.
34. + cells can switch to interleukin 5 production and induce airway eosinophilia. J. Exp. Med. 181:1995;1229-1233.
35. Salgame P., Abrams J.S., Clayberger C., Goldstein H., Convit J., Modlin R.L., et al. Differing lymphocyte profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 245:1991;279-282.
36. Clodi K., Asgari Z., Younes M., Palmer J.L., Cabanillas F., Carbone A., et al. Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin's disease. Cancer. 94:2002;1-5.
37. Gruss H.J., Ulrich D., Braddy S., Armitage R.J., Dower S.K. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Eur. J. Immunol. 25:1995;2083-2089.
38. Annunziata C.M., Safiran Y.I., Irving S.G., Kasid U.N., Cossman J. Hodgkin disease: pharmacologic intervention of the CD40-NFkappaB pathway by a protease inhibitor. Blood. 96:2000;2841-2848.
39. Poppema S, Visser L. The nature of the lymphocytes in Hodgkin's disease. In: Jarrett R, editor. Etiology of Hodgkin's disease. New York: Plenum Press; 1995. p. 169.
40. Poppema S., Lai R., Visser L., Yan X.J. CD45 (leukocyte common antigen) expression in T and B lymphocyte subsets. Leuk. Lymphoma. 20:1996;217-222.
41. Poppema S., Potters M., Visser L., van den Berg A.M. Immune escape mechanisms in Hodgkin's disease. Ann. Oncol. 9:1998;S21-24.